Suspected SSSS
Child with fever, tender erythema, superficial skin peeling
All Pathways
DermatologyEmergency
Staphylococcal Scalded Skin Syndrome (SSSS)
Staphylococcal Scalded Skin Syndrome (SSSS): Suspected SSSS → Recognize Clinical Features → Differentiate from TEN → SSSS Confirmed → Identify S. aureus...
Pathway Overview
14 steps
Algorithm Steps
14 total
01Start 02Action Recognize Clinical Features
Toxin-mediated superficial epidermal disease
- Prodrome: Fever, irritability, skin tenderness
- Erythema: Begins on face, spreads to trunk/extremities
- Nikolsky sign positive: Gentle pressure causes skin to separate
- Superficial blisters that rupture easily
- MUCOUS MEMBRANES SPARED (key differentiator from TEN)
- Usually in children <5 years, neonates
03Decision Differentiate from TEN
Critical distinction - TEN is drug-induced with worse prognosis
- SSSS: Mucous membranes SPARED
- TEN: Mucous membranes ALWAYS involved (mouth, eyes, GU)
- SSSS: Superficial (granular layer) cleavage
- TEN: Full-thickness epidermal necrosis
- SSSS: Usually children
- TEN: Usually adults after medication
- If uncertain: Skin biopsy distinguishes
04Action SSSS Confirmed
Mucous membranes spared, clinical picture consistent
05Action Identify S. aureus Source
Find and treat primary infection
- Skin: Impetigo, wound infection
- Conjunctivae
- Nasopharynx (may be colonization site)
- Umbilicus (neonates)
- Blood cultures if systemically ill
- Culture from site of infection (NOT blisters - usually sterile)
06Action Antistaphylococcal Antibiotics
Start immediately - do not wait for cultures
- MSSA: Nafcillin or Oxacillin 50-100 mg/kg/day IV divided q6h
- Alternative: Cefazolin 50-100 mg/kg/day IV divided q8h
- If MRSA suspected: Vancomycin 40-60 mg/kg/day IV divided q6h
- Or Clindamycin 25-40 mg/kg/day IV divided q8h
- Duration: IV until improving, then oral to complete 7-10 days
- Oral step-down: Cephalexin, dicloxacillin, or clindamycin
07Action Supportive Care
Similar to burn care but less aggressive
- Fluid resuscitation (less than TEN - superficial involvement)
- Temperature regulation - warm environment
- Gentle handling of skin
- Emollients - petroleum-based
- Pain management
- Electrolyte monitoring
- Nutritional support
08Decision Admission Decision
Based on extent and patient factors
09Action Inpatient Management
Most pediatric cases require admission
- Extensive disease (>10% BSA)
- Neonates
- Systemic toxicity
- Unable to take oral medications
- IV antibiotics initially
10Outcome Recovery
Excellent prognosis in children
- Re-epithelialization in 5-7 days
- Complete recovery typically 2 weeks
- NO scarring (superficial cleavage)
- Mortality 1-5% in children
- Recurrence rare
11Warning Complications
Rare but can be serious
- Sepsis (usually from primary infection site)
- Pneumonia
- Cellulitis
- Dehydration/electrolyte imbalance
- Adult SSSS: Mortality 50-60% (underlying comorbidities)
- ICU transfer if hemodynamically unstable
12Action Outpatient (Rare)
Only for mild, localized disease
- Very limited involvement
- Older child, reliable family
- Close follow-up in 24-48 hours
- Clear return precautions
- Path rejoins step 10Shared downstream outcome
13Action Wound Care
Gentle, conservative approach
- Leave blisters intact if possible
- Non-adherent dressings (petrolatum gauze)
- Avoid adhesive tape on affected skin
- Silver sulfadiazine controversial (not usually needed)
- Daily wound assessment
- Path rejoins step 08Shared downstream outcome
14Warning TEN Suspected
Mucosal involvement present
- Refer to SJS/TEN algorithm
- Stop all suspect medications
- Burn unit transfer
- Much higher mortality
Guideline Source
StatPearls: Staphylococcal Scalded Skin Syndrome
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Must differentiate from TEN - different treatment and prognosis
- Adult SSSS carries much higher mortality
- MRSA prevalence may require empiric vancomycin
- Source of S. aureus infection may be occult
- Immunocompromised and renal failure patients at higher risk
Applicable Regions
USEU
Version 1Next review: 2027-01-11
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Staphylococcal Scalded Skin Syndrome (SSSS)?
The Staphylococcal Scalded Skin Syndrome (SSSS) is a emergency clinical algorithm for Dermatology. It provides a structured decision tree to guide clinical decision-making, based on StatPearls: Staphylococcal Scalded Skin Syndrome.
What guideline is the Staphylococcal Scalded Skin Syndrome (SSSS) based on?
This algorithm is based on StatPearls: Staphylococcal Scalded Skin Syndrome.
What are the limitations of the Staphylococcal Scalded Skin Syndrome (SSSS)?
Known limitations include: Must differentiate from TEN - different treatment and prognosis; Adult SSSS carries much higher mortality; MRSA prevalence may require empiric vancomycin; Source of S. aureus infection may be occult; Immunocompromised and renal failure patients at higher risk. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Staphylococcal Scalded Skin Syndrome (SSSS) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free